Home > Insider Trading > Filing (0000921895-16-003644)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
707388	Digirad Corp	DRAD	Electromedical & Electrotherapeutic Apparatus (3845)	330145723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1292031	B Martin Shirley	1048 Industrial Court Suwanee GA 30024	President, Dis	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2016-03-04	9,166	$1.21	16,557	No	4	M	Direct
Common Stock	Acquisiton	2016-03-04	1,162	$1.87	17,719	No	4	M	Direct
Common Stock	Disposition	2016-03-04	10,328	$5.10	7,391	No	4	S	Direct
Common Stock	Acquisiton	2016-03-07	2,455	$1.87	9,846	No	4	M	Direct
Common Stock	Disposition	2016-03-07	2,455	$5.00	7,391	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2016-03-04	9,166	$0.00	9,166	$1.21
Common Stock	Stock Option (right to buy)	Disposition	2016-03-04	1,162	$0.00	1,162	$1.87
Common Stock	Stock Option (right to buy)	Disposition	2016-03-07	2,455	$0.00	2,455	$1.87

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2016-07-09	No	4	M	Direct
38,838	2017-02-16	No	4	M	Direct
36,383	2017-02-16	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.06 to $5.19, inclusive. The reporting person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold.
The option, representing a right to purchase a total of 9,166 shares, became fully vested and exercisable on the date on which the option was granted.
The option, representing a right to purchase a total of 40,000 shares, became vested and exercisable in forty-eight equal monthly installments beginning on the vesting commencement date of February 16, 2010, over a four-year period on the same day of the month, until all the shares beame fully vested and exercisable, subject to the reporting person continuing to provide service through each such date.